Luther T Clark

Summary

Affiliation: State University of New York
Country: USA

Publications

  1. ncbi The epidemic of diabetes mellitus and the metabolic syndrome in African Americans
    Keith C Ferdinand
    Xavier University College of Pharmacy, Heartbeats Life Center, New Orleans, Louisiana, USA
    Rev Cardiovasc Med 5:S28-33. 2004
  2. ncbi Direct thrombin inhibitor use during percutaneous coronary intervention
    Spyros Kokolis
    State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203, USA
    J Cardiovasc Pharmacol 45:270-9. 2005
  3. ncbi Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial
    Keith C Ferdinand
    Heartbeats Life Center, Xavier University College of Pharmacy, New Orleans, Louisiana, USA
    Am J Cardiol 97:229-35. 2006
  4. ncbi Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era
    Edward L Hannan
    State University of New York, University at Albany, Rensselaer, NY 12144 3456, USA
    Circulation 113:2406-12. 2006
  5. ncbi Home blood pressure monitoring in an ethnically diverse inner-city cardiology practice
    Ghazanfar Qureshi
    Division of Cardiovascular Medicine, State University of New York, Downstate Medical Center, 450 Clarkson Ave, Brooklyn 11203 2098, USA
    Ethn Dis 18:37-41. 2008
  6. ncbi Vascular inflammation as a therapeutic target for prevention of cardiovascular disease
    Luther T Clark
    Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, 450 Clarkson Avenue, Box 1199, Brooklyn, NY 11203, USA
    Curr Atheroscler Rep 4:77-81. 2002
  7. ncbi Metabolic syndrome in African Americans: implications for preventing coronary heart disease
    Luther T Clark
    Professor of Clinical Medicine, Chief, Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203, USA
    Clin Cardiol 30:161-4. 2007
  8. ncbi Issues in minority health: atherosclerosis and coronary heart disease in African Americans
    Luther T Clark
    Division of Cardiovascular Medicine, Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203, USA
    Med Clin North Am 89:977-1001, 994. 2005
  9. ncbi Treating dyslipidemia with statins: the risk-benefit profile
    Luther T Clark
    Division of Cardiovascular Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY 11203, USA
    Am Heart J 145:387-96. 2003
  10. ncbi Optimizing lipid lowering in patients at risk
    Luther T Clark
    Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203 2098, USA
    Clin Cardiol 27:III22-6. 2004

Detail Information

Publications46

  1. ncbi The epidemic of diabetes mellitus and the metabolic syndrome in African Americans
    Keith C Ferdinand
    Xavier University College of Pharmacy, Heartbeats Life Center, New Orleans, Louisiana, USA
    Rev Cardiovasc Med 5:S28-33. 2004
    ..Appropriate lifestyle modification programs, glucose control, and cardiovascular risk reduction therapy will reduce the excessive morbidity and mortality in this population...
  2. ncbi Direct thrombin inhibitor use during percutaneous coronary intervention
    Spyros Kokolis
    State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203, USA
    J Cardiovasc Pharmacol 45:270-9. 2005
    ..We review the pharmacological properties of these newer antithrombotic agents and evaluate the clinical data demonstrating their use in patients undergoing PCI...
  3. ncbi Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial
    Keith C Ferdinand
    Heartbeats Life Center, Xavier University College of Pharmacy, New Orleans, Louisiana, USA
    Am J Cardiol 97:229-35. 2006
    ..In conclusion, rosuvastatin 10 and 20 mg improved the overall lipid profile of hypercholesterolemic African-Americans better than did milligram-equivalent doses of atorvastatin...
  4. ncbi Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era
    Edward L Hannan
    State University of New York, University at Albany, Rensselaer, NY 12144 3456, USA
    Circulation 113:2406-12. 2006
    ....
  5. ncbi Home blood pressure monitoring in an ethnically diverse inner-city cardiology practice
    Ghazanfar Qureshi
    Division of Cardiovascular Medicine, State University of New York, Downstate Medical Center, 450 Clarkson Ave, Brooklyn 11203 2098, USA
    Ethn Dis 18:37-41. 2008
    ..To evaluate home blood pressure monitoring (HBPM) in an inner city cardiology practice...
  6. ncbi Vascular inflammation as a therapeutic target for prevention of cardiovascular disease
    Luther T Clark
    Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, 450 Clarkson Avenue, Box 1199, Brooklyn, NY 11203, USA
    Curr Atheroscler Rep 4:77-81. 2002
  7. ncbi Metabolic syndrome in African Americans: implications for preventing coronary heart disease
    Luther T Clark
    Professor of Clinical Medicine, Chief, Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203, USA
    Clin Cardiol 30:161-4. 2007
    ..Although all components of the metabolic syndrome should be addressed, optimal control of atherogenic dyslipidemia and elevated blood pressure may reduce cardiovascular risk by more than 80%...
  8. ncbi Issues in minority health: atherosclerosis and coronary heart disease in African Americans
    Luther T Clark
    Division of Cardiovascular Medicine, Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203, USA
    Med Clin North Am 89:977-1001, 994. 2005
    ....
  9. ncbi Treating dyslipidemia with statins: the risk-benefit profile
    Luther T Clark
    Division of Cardiovascular Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY 11203, USA
    Am Heart J 145:387-96. 2003
    ..Central to the pathogenesis of atherosclerosis are the deposition and retention of cholesterol in the arterial walls. Lipid modification, therefore, is key to CHD prevention...
  10. ncbi Optimizing lipid lowering in patients at risk
    Luther T Clark
    Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203 2098, USA
    Clin Cardiol 27:III22-6. 2004
    ..Several ongoing trials are evaluating whether the benefit of simultaneously blocking cholesterol synthesis and intestinal cholesterol absorption translates into better clinical outcomes...
  11. ncbi Acute coronary syndromes in black Americans: is treatment different? Should it be?
    Luther T Clark
    Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, Brooklyn, NY 11203, USA
    Curr Cardiol Rep 7:249-54. 2005
    ..Changing this and improving care for ACS in blacks requires better strategies for decreasing patient delays, earlier recognition and diagnosis of ACS, and more effective implementation of evidence-based treatment guidelines...
  12. ncbi Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
    Am J Cardiol 99:1364-8. 2007
    ..34 ng/ml was 88% compared with 74% in those whose values were >20.34 ng/ml (p = 0.0249 by log-rank test). In conclusion, these data demonstrate that baseline MPO levels independently predict MI at 2 years in patients with ACS...
  13. ncbi Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography
    Erdal Cavusoglu
    Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York, USA
    Am J Cardiol 98:1189-93. 2006
    ....
  14. ncbi Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 1257, Brooklyn, NY 11203 2098, USA
    Arterioscler Thromb Vasc Biol 27:929-35. 2007
    ..RANTES is a chemokine produced by a variety of cell types including platelets that has been implicated in atherosclerosis...
  15. ncbi A risk score to predict in-hospital mortality for percutaneous coronary interventions
    Chuntao Wu
    University at Albany, State University of New York, Albany, New York, USA
    J Am Coll Cardiol 47:654-60. 2006
    ..Our purpose was to develop a risk score to predict in-hospital mortality for percutaneous coronary intervention (PCI) using a statewide population-based PCI registry...
  16. ncbi A comparison of mortality, myocardial infarction, and repeated revascularization for sirolimus-eluting and paclitaxel-eluting coronary stents
    Edward L Hannan
    School of Public Health, University at Albany, State University of New York, Albany, NY 12144 3456, USA
    Am Heart J 154:545-53. 2007
    ..There are only 2 approved devices: sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES). Only a few population-based studies have compared their patient outcomes...
  17. ncbi Usefulness of the serum complement component C4 as a predictor of stroke in patients with known or suspected coronary artery disease referred for coronary angiography
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
    Am J Cardiol 100:164-8. 2007
    ..In conclusion, in a cohort of men across a spectrum of risk referred for coronary angiography, a single baseline determination of serum complement C4 level is an independent predictor of the future development of stroke...
  18. ncbi Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 1257, Brooklyn, NY 11203 2098, USA
    Eur Heart J 27:2300-9. 2006
    ..To determine the prognostic value of baseline plasma adiponectin levels in patients with known or suspected coronary artery disease referred for coronary angiography...
  19. ncbi Differences in utilization of drug-eluting stents by race and payer
    Edward L Hannan
    University at Albany, State University of New York, Albany, NY, USA
    Am J Cardiol 100:1192-8. 2007
    ..93) and 0.85, 95% CI 0.75 to 0.96). In conclusion, African-Americans and low income groups receive DES less frequently than their counterparts compared with BMS. This is related to the hospitals where they are admitted, but not entirely...
  20. ncbi Effects of alcoholism on coronary artery disease and left ventricular dysfunction in male veterans
    Spyros Kokolis
    S U N Y Downstate Medical Center, Brooklyn, New York, USA
    J Invasive Cardiol 18:304-7. 2006
    ..The objective of this study was to compare coronary anatomy and left ventricular dysfunction in patients with and without alcoholism associated with heavy consumption...
  21. ncbi Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203 2098, USA
    J Am Coll Cardiol 50:1768-76. 2007
    ..The purpose of this study was to determine the association of the F11 receptor (F11R) with human vascular disease...
  22. ncbi Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome
    Erdal Cavusoglu
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
    Am J Cardiol 98:580-4. 2006
    ..0065 by log-rank test). In conclusion, these data demonstrate that baseline anemia is a strong and independent predictor of death or AMI at 2 years in patients with ACS...
  23. ncbi Impact of gender on in-hospital percutaneous coronary interventional outcomes in African-Americans
    Shyam Poludasu
    Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, New York, USA
    J Invasive Cardiol 19:123-8. 2007
    ..The impact of gender on post-PCI outcomes in African-Americans has not been reported...
  24. ncbi Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction
    Erdal Cavusoglu
    Department of Medicine, State University of New York Health Science Center, Brooklyn, NY 11203 2098, USA
    Am Heart J 151:1101.e1-8. 2006
    ..The prognostic value of plasma tissue inhibitor of metalloproteinase-1 (TIMP-1) levels in patients with established or suspected coronary artery disease is unknown...
  25. pmc Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components
    Girardin Jean-Louis
    Brooklyn Center for Health Disparities, SUNY Downstate Medical Center Brooklyn, NY 11203 2098, USA
    J Clin Sleep Med 4:261-72. 2008
    ..e., central obesity, hypertension, diabetes, and dyslipidemia). Large-scale, population-based studies testing causal models linking among sleep apnea, cardiovascular morbidity, and metabolic syndrome are needed...
  26. ncbi Percutaneous coronary intervention in a patient with congenital factor XI deficiency and acquired inhibitor
    Sudhir Mungee
    Division of Cardiology, SUNY Downstate Medical Center, Brooklyn, NY 11203 2098, USA
    Cardiology 107:69-72. 2007
    ..Immunosuppressive therapy, plasma exchange and factor VII product transfusions have been used prior to cardiac interventions in few such reported cases...
  27. pmc Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II
    Luther T Clark
    State University of New York Downstate Medical Center, Brooklyn, NY, USA
    J Gen Intern Med 21:320-6. 2006
    ..Data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey were used to assess ethnic differences in low-density lipoprotein cholesterol (LDL-C) goal achievement...
  28. ncbi Bedside ultrasound diagnosis of aortic dissection in a cocaine abuser
    Vijay Divakaran
    State University of New York Downstate Medical Center, Brooklyn, NY, USA
    Eur J Intern Med 18:595-6. 2007
    ..This case report describes a patient with cocaine-induced myocardial infarction who was also found to have a type A aortic dissection. Interestingly, this potentially fatal complication was detected by a bedside 2D echocardiogram...
  29. ncbi Changes in QT dispersion after thrombolysis for stroke
    Jason Lazar
    Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203 2098, USA
    Int J Cardiol 125:258-62. 2008
    ..Although largely studied in patients with cardiovascular disease, QTD is increased in acute stroke and this finding is an independent predictor of functional outcome and mortality following acute neurological events...
  30. ncbi Ventricular arrhythmias and sudden cardiac death
    Spyros Kokolis
    Downstate Medical Center, State University of New York, 450 Clarkson Avenue, Brooklyn, NY 11203, USA
    Prog Cardiovasc Dis 48:426-44. 2006
  31. ncbi Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint
    Peter M Okin
    Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    Am J Hypertens 15:663-71. 2002
    ..However, the high mortality associated with LVH in African American patients makes more accurate ECG detection of LVH in these patients a clinical priority...
  32. ncbi Volume-outcome relationships for percutaneous coronary interventions in the stent era
    Edward L Hannan
    State University of New York, Albany, NY, USA
    Circulation 112:1171-9. 2005
    ..Most studies that are the basis of recommended volume thresholds for percutaneous coronary interventions (PCIs) predate the routine use of stent placement...
  33. ncbi Anticoagulation strategies for patients undergoing percutaneous coronary intervention: unfractionated heparin, low-molecular-weight heparins, and direct thrombin inhibitors
    Spyros Kokolis
    State University of New York, Health Science Center at Brooklyn, 11203, USA
    Prog Cardiovasc Dis 46:506-23. 2004
    ..This paper reviews the pharmacologic properties of these newer antithrombotic agents and evaluates the clinical data demonstrating their use in patients undergoing PCI...
  34. ncbi Relationship of lower extremity skin blood flow to the ankle brachial index in patients with peripheral arterial disease and normal volunteers
    Kenneth E Otah
    Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA
    Int J Cardiol 103:41-6. 2005
    ..94, p=0.001 for detecting PAD. Skin blood flow by this method correlates with the presence and severity of an abnormal ABI. This may offer a method of monitoring the effect of therapy and regression of peripheral atherosclerosis...
  35. ncbi The metabolic syndrome: recognition and management
    W Dallas Hall
    Emory University School of Medicine, Atlanta, GA, USA
    Dis Manag 9:16-33. 2006
    ..Pharmacotherapy is typically needed for control of high blood pressure, hypercoagulability, and increased levels of blood glucose and triglycerides...
  36. ncbi A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
    Scott M Grundy
    Arterioscler Thromb Vasc Biol 24:1329-30. 2004
  37. ncbi Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
    Scott M Grundy
    Circulation 110:227-39. 2004
    ..Finally, for people in lower-risk categories, recent clinical trials do not modify the goals and cutpoints of therapy...
  38. ncbi Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
    Scott M Grundy
    Arterioscler Thromb Vasc Biol 24:e149-61. 2004
    ..Finally, for people in lower-risk categories, recent clinical trials do not modify the goals and cutpoints of therapy...
  39. ncbi Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: management of cardiovascular-renal complications
    Robert O Bonow
    Circulation 105:e159-64. 2002
  40. ncbi Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
    Scott M Grundy
    J Am Coll Cardiol 44:720-32. 2004
    ..Finally, for people in lower-risk categories, recent clinical trials do not modify the goals and cutpoints of therapy...
  41. ncbi Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group
    Sidney C Smith
    Circulation 111:e134-9. 2005
  42. ncbi For the patient. What is the Metabolic Syndrome and why is it important?
    W Dallas Hall
    Ethn Dis 13:546. 2003
  43. ncbi Task Force 6: coronary artery disease
    Paul D Thompson
    J Am Coll Cardiol 45:1348-53. 2005
  44. ncbi Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations
    Michael H Davidson
    Radiant Development, Chicago, Illinois, USA
    Am J Cardiol 96:556-63. 2005
    ..Most of those (75%) with cardiovascular disease in NEPTUNE II would be considered very high risk and candidates for aggressive therapy to reach the new optional treatment goals...
  45. ncbi Usefulness of an abnormal ankle-brachial index to predict presence of coronary artery disease in African-Americans
    Kenneth Ese Otah
    Division of Cardiology, University of Texas Health Science Center at Houston, Houston, Texas 77030, USA
    Am J Cardiol 93:481-3. 2004
    ..However, a normal ABI did not predict absence of 1- or 2-vessel CAD. These results suggest that in this population, the ABI can be used to increase the pretest probability of severe CAD...
  46. ncbi The Metabolic Syndrome in African Americans: a review
    W Dallas Hall
    African American Lipid and Cardiovascular Council, USA
    Ethn Dis 13:414-28. 2003
    ..This comprehensive review is provided as part of the educational activities of the African-American Lipid and Cardiovascular Council (AALCC)...